Home › NDC Lookup › RxCUI directory › RxCUI 1110816

Benzocaine 75 MG/ML Mucosal Spray — RxCUI 1110816

Name: Benzocaine 75 MG/ML Mucosal Spray (RxCUI 1110816)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 1110816 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1110816

Official nameBenzocaine 75 MG/ML Mucosal Spray

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known asbenzocaine 7.5 % Mucosal Spray

FDA products mapped2

Package NDCs mapped2

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

🕸️ Concept Web — How Benzocaine 75 MG/ML Mucosal Spray Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Benzocaine 75 MG/ML Mucosal Spray RxCUI 1110816 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Benzocaine 1399 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Finafta Multi Oral 1110817 BN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Benzocaine Mucosal Spray 379061 SCDF
- Benzocaine Mucosal Product 1152967 SCDG
- Benzocaine Mucosal Spray [Finafta Multi Oral] 1110819 SBDF
- Finafta Multi Oral Mucosal Product 1168320 SBDG
- Mucosal Spray 346163 DF
- Mucosal Product 1151129 DFG
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Benzocaine 75 MG/ML 329215 SCDC
- Benzocaine 75 MG/ML Mucosal Spray [Finafta Multi Oral] 1110820 SBD
- Benzocaine 75 MG/ML [Finafta Multi Oral] 1110818 SBDC

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Benzocaine 75 MG/ML SCDC · 329215
Benzocaine Mucosal Spray SCDF · 379061
Benzocaine Mucosal Product SCDG · 1152967

Brand-Name Concepts

Benzocaine 75 MG/ML Mucosal Spray [Finafta Multi Oral] SBD · 1110820
Benzocaine 75 MG/ML [Finafta Multi Oral] SBDC · 1110818
Benzocaine Mucosal Spray [Finafta Multi Oral] SBDF · 1110819
Finafta Multi Oral Mucosal Product SBDG · 1168320
Finafta Multi Oral BN · 1110817

📦 FDA Products & Package NDCs

2 products · 2 package NDCs

2 package NDCs map to RxCUI 1110816 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
58593-0782-02	1 BOTTLE, SPRAY in 1 CARTON (58593-782-02) / 59 mL in 1 BOT...	Finafta MultiOral	Efficient Laboratories Inc.	2004-09-01
65852-0001-02	1 BOTTLE, SPRAY in 1 CARTON (65852-001-02) / 59 mL in 1 BOT...	Finafta MultiOral	Dextrum Laboratories Inc.	2004-09-01

Observed labelers: Dextrum Laboratories Inc. (1) · Efficient Laboratories Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.